ArticleJournal of molecular histology2025
Upregulation of Caspase-3 and TNF-α in a rat model of cerebellar motor disorder: role of Cucumis sativus (cucumber).
Article in Journal of molecular histology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebellar Motor Disorders (CMDs) are characterized by unsteady gait and uncoordinated movements. Reports indicate that CMDs are caused by congenital malformations, hereditary ataxia, and heavy metal exposure, such as Lead. The antioxidant-rich nature of plants, such as Cucumis sativus (Cucumber), has been well-documented. Accordingly, this study investigated the protective activity of aqueous Cucumis sativus fruit extract (CS) in a lead acetate (Pb) rat model of CMD. Forty Wistar rats (n = 8) were randomly assigned into five groups and treated for twenty-eight days as follows: Group A served as control; Group B received 100 mg/kg body weight (bw) of Pb; Group C received 500 mg/kg bw of CS and Pb; Group D received 1000 mg/kg bw of CS and Pb; Group E received 200 mg/kg bw of Vitamin-E and Pb. Thereafter, neurobehavioral activities, antioxidant enzymes, lipid peroxidation, nitric oxide, Pb concentration, Caspase-3, TNF-α, and cerebella histology were evaluated. Findings revealed that Pb-exposed rats demonstrated significant (p < 0.05) weight loss, impaired motor functions, dysregulated antioxidant enzymes activity, increased lipid peroxidation, elevated cerebellar nitric oxide and Pb concentration, as well as degenerating Purkinje cells and vacuolations in the cerebellum. Also, a significant upregulation (p < 0.05) of Caspase-3 and TNF-α was observed in the cerebella of Pb-exposed rats. However, pretreatment with CS mitigated (p < 0.05) these adverse effects induced by Pb. Taken together, this study offers novel insights into the role of CS as a promising neuroprotective agent and provides translational research evidence demonstrating that CS can be further developed into drugs useful against CMDs.
Indexed as
Identifiers
40493089What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.